Literature DB >> 25315662

Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.

Przemyslaw Szafranski1, Sailaja Golla2, Weihong Jin1, Ping Fang1, Patricia Hixson1, Reuben Matalon3, Daniel Kinney4, Hans-Georg Bock5, William Craigen1, Janice L Smith1, Weimin Bi1, Ankita Patel1, Sau Wai Cheung1, Carlos A Bacino1, Paweł Stankiewicz1.   

Abstract

Point mutations and genomic deletions of the CDKL5 (STK9) gene on chromosome Xp22 have been reported in patients with severe neurodevelopmental abnormalities, including Rett-like disorders. To date, only larger-sized (8-21 Mb) duplications harboring CDKL5 have been described. We report seven females and four males from seven unrelated families with CDKL5 duplications 540-935 kb in size. Three families of different ethnicities had identical 667kb duplications containing only the shorter CDKL5 isoform. Four affected boys, 8-14 years of age, and three affected girls, 6-8 years of age, manifested autistic behavior, developmental delay, language impairment, and hyperactivity. Of note, two boys and one girl had macrocephaly. Two carrier mothers of the affected boys reported a history of problems with learning and mathematics while at school. None of the patients had epilepsy. Similarly to CDKL5 mutations and deletions, the X-inactivation pattern in all six studied females was random. We hypothesize that the increased dosage of CDKL5 might have affected interactions of this kinase with its substrates, leading to perturbation of synaptic plasticity and learning, and resulting in autistic behavior, developmental and speech delay, hyperactivity, and macrocephaly.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25315662      PMCID: PMC4463505          DOI: 10.1038/ejhg.2014.217

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  53 in total

1.  Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features.

Authors:  Nils Rademacher; Melanie Hambrock; Ute Fischer; Bettina Moser; Berten Ceulemans; Wolfgang Lieb; Rainer Boor; Irina Stefanova; Gabriele Gillessen-Kaesbach; Charlotte Runge; Georg Christoph Korenke; Stefanie Spranger; Franco Laccone; Andreas Tzschach; Vera M Kalscheuer
Journal:  Neurogenetics       Date:  2011-02-12       Impact factor: 2.660

2.  CDKL5 is a brain MeCP2 target gene regulated by DNA methylation.

Authors:  Delphine Carouge; Lionel Host; Dominique Aunis; Jean Zwiller; Patrick Anglard
Journal:  Neurobiol Dis       Date:  2010-03-06       Impact factor: 5.996

3.  West syndrome associated with mosaic duplication of FOXG1 in a patient with maternal uniparental disomy of chromosome 14.

Authors:  Jun Tohyama; Toshiyuki Yamamoto; Kana Hosoki; Keisuke Nagasaki; Noriyuki Akasaka; Tsukasa Ohashi; Yu Kobayashi; Shinji Saitoh
Journal:  Am J Med Genet A       Date:  2011-09-09       Impact factor: 2.802

4.  CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.

Authors:  N Bahi-Buisson; T Bienvenu
Journal:  Mol Syndromol       Date:  2011-09-13

5.  CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.

Authors:  Laura Rusconi; Lisa Salvatoni; Laura Giudici; Ilaria Bertani; Charlotte Kilstrup-Nielsen; Vania Broccoli; Nicoletta Landsberger
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

Review 6.  Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature.

Authors:  C Nemos; L Lambert; F Giuliano; B Doray; A Roubertie; A Goldenberg; B Delobel; V Layet; M A N'guyen; A Saunier; F Verneau; P Jonveaux; C Philippe
Journal:  Clin Genet       Date:  2009-10       Impact factor: 4.438

7.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.

Authors:  Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski
Journal:  J Med Genet       Date:  2009-11-12       Impact factor: 6.318

8.  Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes.

Authors:  S Russo; M Marchi; F Cogliati; M T Bonati; M Pintaudi; E Veneselli; V Saletti; M Balestrini; B Ben-Zeev; L Larizza
Journal:  Neurogenetics       Date:  2009-02-25       Impact factor: 2.660

9.  Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities.

Authors:  Nicola Brunetti-Pierri; Jonathan S Berg; Fernando Scaglia; John Belmont; Carlos A Bacino; Trilochan Sahoo; Seema R Lalani; Brett Graham; Brendan Lee; Marwan Shinawi; Joseph Shen; Sung-Hae L Kang; Amber Pursley; Timothy Lotze; Gail Kennedy; Susan Lansky-Shafer; Christine Weaver; Elizabeth R Roeder; Theresa A Grebe; Georgianne L Arnold; Terry Hutchison; Tyler Reimschisel; Stephen Amato; Michael T Geragthy; Jeffrey W Innis; Ewa Obersztyn; Beata Nowakowska; Sally S Rosengren; Patricia I Bader; Dorothy K Grange; Sayed Naqvi; Adolfo D Garnica; Saunder M Bernes; Chin-To Fong; Anne Summers; W David Walters; James R Lupski; Pawel Stankiewicz; Sau Wai Cheung; Ankita Patel
Journal:  Nat Genet       Date:  2008-12       Impact factor: 38.330

10.  CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders.

Authors:  Clark Lin; Brunella Franco; Marsha Rich Rosner
Journal:  Hum Mol Genet       Date:  2005-12-05       Impact factor: 6.150

View more
  20 in total

1.  Aminoglycoside drugs induce efficient read-through of CDKL5 nonsense mutations, slightly restoring its kinase activity.

Authors:  Maria Fazzari; Angelisa Frasca; Francesco Bifari; Nicoletta Landsberger
Journal:  RNA Biol       Date:  2019-06-23       Impact factor: 4.652

Review 2.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

3.  Proof-of-concept for a gene replacement approach to CDKL5 deficiency disorder.

Authors:  Tim A Benke; Peter C Kind
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

4.  Genetic Counselling Pitfall: Co-Occurrence of an 11.8-Mb Xp22 Duplication and an Xp21.2 Duplication Disrupting IL1RAPL1.

Authors:  Nicolas Chatron; Lucie Thibault; James Lespinasse; Audrey Labalme; Caroline Schluth-Bolard; Marianne Till; Patrick Edery; Renaud Touraine; Vincent des Portes; Gaetan Lesca; Damien Sanlaville
Journal:  Mol Syndromol       Date:  2017-09-07

5.  Synaptic synthesis, dephosphorylation, and degradation: a novel paradigm for an activity-dependent neuronal control of CDKL5.

Authors:  Paolo La Montanara; Laura Rusconi; Albina Locarno; Lia Forti; Isabella Barbiero; Marco Tramarin; Chetan Chandola; Charlotte Kilstrup-Nielsen; Nicoletta Landsberger
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

Review 6.  Autism, epilepsy, and synaptopathies: a not rare association.

Authors:  Roberto Keller; Roberta Basta; Luana Salerno; Maurizio Elia
Journal:  Neurol Sci       Date:  2017-04-28       Impact factor: 3.307

7.  Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits.

Authors:  Barbara Terzic; M Felicia Davatolhagh; Yugong Ho; Sheng Tang; Yu-Ting Liu; Zijie Xia; Yue Cui; Marc V Fuccillo; Zhaolan Zhou
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

8.  Alu-mediated diverse and complex pathogenic copy-number variants within human chromosome 17 at p13.3.

Authors:  Shen Gu; Bo Yuan; Ian M Campbell; Christine R Beck; Claudia M B Carvalho; Sandesh C S Nagamani; Ayelet Erez; Ankita Patel; Carlos A Bacino; Chad A Shaw; Paweł Stankiewicz; Sau Wai Cheung; Weimin Bi; James R Lupski
Journal:  Hum Mol Genet       Date:  2015-04-23       Impact factor: 6.150

9.  Prevalence and onset of comorbidities in the CDKL5 disorder differ from Rett syndrome.

Authors:  Meghana Mangatt; Kingsley Wong; Barbara Anderson; Amy Epstein; Stuart Hodgetts; Helen Leonard; Jenny Downs
Journal:  Orphanet J Rare Dis       Date:  2016-04-14       Impact factor: 4.123

10.  X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.

Authors:  Barbara Terzic; Yue Cui; Andrew C Edmondson; Sheng Tang; Nicolas Sarmiento; Daria Zaitseva; Eric D Marsh; Douglas A Coulter; Zhaolan Zhou
Journal:  Neurobiol Dis       Date:  2020-11-13       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.